Literature DB >> 29153138

p-cresol sulfate and indoxyl sulfate: some clouds are gathering in the uremic toxin sky.

Pieter Evenepoel1, Griet Glorieux2, Bjorn Meijers3.   

Abstract

An increasing body of experimental and clinical evidence suggests that p-cresol sulfate and indoxyl sulfate contribute to the high cardiovascular burden in patients with chronic kidney disease. In a post hoc analysis on the HEMO trial, Shafi et al. failed to confirm an association between total p-cresol sulfate and indoxyl sulfate and cardiovascular outcomes in dialysis patients. Analytical issues and case-mix may explain the discrepant findings.
Copyright © 2017 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29153138     DOI： 10.1016/j.kint.2017.06.029

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  9 in total

Review 1.  The role of chronic kidney disease-associated dysbiosis in cardiovascular disease.

Authors:  Mark A Bryniarski; Fares Hamarneh; Rabi Yacoub
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-25

2.  Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug-Bug Interaction?

Authors:  Lu Dai; Björn K Meijers; Bert Bammens; Henriette de Loor; Leon J Schurgers; Abdul Rashid Qureshi; Peter Stenvinkel; Pieter Evenepoel
Journal:  Toxins (Basel)       Date:  2020-05-27       Impact factor: 4.546

Review 3.  Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.

Authors:  Iwona Filipska; Agata Winiarska; Monika Knysak; Tomasz Stompór
Journal:  Toxins (Basel)       Date:  2021-04-10       Impact factor: 4.546

Review 4.  Medium Cut-Off Dialysis Membrane and Dietary Fiber Effects on Inflammation and Protein-Bound Uremic Toxins: A Systematic Review and Protocol for an Interventional Study.

Authors:  Tjaša Herič; Tjaša Vivoda; Špela Bogataj; Jernej Pajek
Journal:  Toxins (Basel)       Date:  2021-03-29       Impact factor: 4.546

5.  Contribution of Hypoalbuminemia and Anemia to the Prognostic Value of Plasma p-Cresyl Sulfate and p-Cresyl Glucuronide for Cardiovascular Outcome in Chronic Kidney Disease.

Authors:  Francis Verbeke; Raymond Vanholder; Wim Van Biesen; Griet Glorieux
Journal:  J Pers Med       Date:  2022-07-28

6.  The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.

Authors:  Aleksey Etinger; Sumit R Kumar; William Ackley; Leland Soiefer; Jonathan Chun; Prabjhot Singh; Eric Grossman; Albert Matalon; Robert S Holzman; Bjorn Meijers; Jerome Lowenstein
Journal:  PLoS One       Date:  2018-02-22       Impact factor: 3.240

7.  Supplementation of Short-Chain Fatty Acid, Sodium Propionate, in Patients on Maintenance Hemodialysis: Beneficial Effects on Inflammatory Parameters and Gut-Derived Uremic Toxins, A Pilot Study (PLAN Study)

Authors:  Stefania Marzocco; Gholamreza Fazeli; Lucia Di Micco; Giuseppina Autore; Simona Adesso; Fabrizio Dal Piaz; August Heidland; Biagio Di Iorio
Journal:  J Clin Med       Date:  2018-09-30       Impact factor: 4.241

8.  A combination of monosodium glutamate and high-fat and high-fructose diets increases the risk of kidney injury, gut dysbiosis and host-microbial co-metabolism.

Authors:  Thatsanapong Pongking; Ornuma Haonon; Rungtiwa Dangtakot; Sudarat Onsurathum; Apinya Jusakul; Kitti Intuyod; Arunnee Sangka; Sirirat Anutrakulchai; Ubon Cha'on; Somchai Pinlaor; Porntip Pinlaor
Journal:  PLoS One       Date:  2020-04-08       Impact factor: 3.240

9.  Dietary Fibre Intake Is Associated with Serum Levels of Uraemic Toxins in Children with Chronic Kidney Disease.

Authors:  Amina El Amouri; Evelien Snauwaert; Aurélie Foulon; Charlotte Vande Moortel; Maria Van Dyck; Koen Van Hoeck; Nathalie Godefroid; Griet Glorieux; Wim Van Biesen; Johan Vande Walle; Ann Raes; Sunny Eloot
Journal:  Toxins (Basel)       Date:  2021-03-19       Impact factor: 4.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.